Processing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes.
about
Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia veraA novel unconventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia veraInflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.Caspase-1 recognizes extended cleavage sites in its natural substratesStructural evidence of anti-atherogenic microRNAsAnalysis for Carom complex, signaling and function by database mining.Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets--"Sand Out and Gold Stays".Homocysteine induces inflammatory transcriptional signaling in monocytesThe Role of Immunogenicity in Cardiovascular Disease.HLA-A2.1-restricted T cells react to SEREX-defined tumor antigen CML66L and are suppressed by CD4+CD25+ regulatory T cells.A comprehensive data mining study shows that most nuclear receptors act as newly proposed homeostasis-associated molecular pattern receptors.GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.DNA Checkpoint and Repair Factors Are Nuclear Sensors for Intracellular Organelle Stresses-Inflammations and Cancers Can Have High Genomic Risks.
P2860
Q33264010-E61A321C-3E21-4D8C-B0B2-A1B4FD152E57Q33290521-B68566FA-D34D-417C-90DB-37A2262D3337Q33805176-B76357A1-5531-43B4-8FBF-0E34AA1F82DDQ34048288-E5657D81-C04A-4536-AD5C-5E0901C8032CQ35017677-D082B65B-5E73-45ED-8CD5-F81D24BFF353Q36604293-C12EEAFF-A333-4A5C-83FF-940A1B45E3E5Q36619589-7F18596B-58A1-4C7A-B04B-025700A3CDD2Q36795830-C27A2794-8B3C-466E-A494-9084C35D9AE0Q37560012-0F270C88-7A3A-47A1-82BE-1E9BC4F7FAD7Q40161787-5E1DF16E-1092-49CB-B57A-111833E42A29Q42634180-B9026CA9-6ECD-40A7-895E-23BE410CD12FQ49474705-70E28582-9F95-413F-BCC2-4D020199D595Q55231975-D81AD1FE-12FF-4690-8EE4-DF7F815C85C4
P2860
Processing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Processing sites are different ...... n epitopes and viral epitopes.
@en
type
label
Processing sites are different ...... n epitopes and viral epitopes.
@en
prefLabel
Processing sites are different ...... n epitopes and viral epitopes.
@en
P2093
P2860
P1476
Processing sites are different ...... n epitopes and viral epitopes.
@en
P2093
D Mirkovic
P2860
P304
P356
10.1177/039463200601900415
P577
2006-10-01T00:00:00Z